CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.
about
CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
CD30-targeted oncolytic viruse ...... st classical Hodgkin lymphoma.
@en
CD30-targeted oncolytic viruse ...... st classical Hodgkin lymphoma.
@nl
type
label
CD30-targeted oncolytic viruse ...... st classical Hodgkin lymphoma.
@en
CD30-targeted oncolytic viruse ...... st classical Hodgkin lymphoma.
@nl
prefLabel
CD30-targeted oncolytic viruse ...... st classical Hodgkin lymphoma.
@en
CD30-targeted oncolytic viruse ...... st classical Hodgkin lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
CD30-targeted oncolytic viruse ...... st classical Hodgkin lymphoma.
@en
P2093
Alexander Muik
Anett Pfeiffer
Benjamin Rengstl
Christian J Buchholz
Dina Kleinlützum
Irene C Schneider
Johanna Reul
Julia D S Hanauer
Martin-Leo Hansmann
Sebastian Newrzela
P2860
P304
12971-12981
P356
10.18632/ONCOTARGET.24191
P407
P577
2018-01-12T00:00:00Z